We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPYM
1326
State Street SPDR Portfolio S&P 500 ETF
SPYM
$160B
| $2.08M | ﹤0.01% |
+32,534
| New | +$2M |
|
1327
RadNet
RDNT
$4.97B
| $2.08M | ﹤0.01% |
35,238
-80,896
| -70% | -$4.39M |
|
1328
MiMedx Group
MDXG
$649M
| $2.07M | ﹤0.01% |
298,818
+3,223
| +1% | +$22.7K |
|
1329
Fulcrum Therapeutics
FULC
$248M
| $2.07M | ﹤0.01% |
333,161
+107,588
| +48% | +$815K |
|
|
SLAMW
1330
CALL
DELISTED
Slam Corp. warrant
SLAMW
| $2.06M | ﹤0.01% |
185,499
-114,501
| -38% | -$20.2K |
|
1331
LeMaitre Vascular
LMAT
$2.34B
| $2.06M | ﹤0.01% |
25,019
-19,921
| -44% | -$1.46M |
|
|
ARCH
1332
DELISTED
Arch Resources, Inc.
ARCH
| $2.06M | ﹤0.01% |
+13,503
| New | +$2.17M |
|
1333
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
| $2.05M | ﹤0.01% |
48,200
+48,100
| +48,100% | +$2.02M |
|
1334
Valley National Bancorp
VLY
$8.01B
| $2.05M | ﹤0.01% |
+293,422
| New | +$2.14M |
|
|
TGAAW
1335
CALL
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
| $2.04M | ﹤0.01% |
180,264
| – | – |
|
|
AMODW
1336
CALL
Alpha Modus Holdings Warrant
AMODW
$256K
| $2.04M | ﹤0.01% |
180,000
-21,275
| -11% | -$917 |
|
1337
BlackBerry
BB
$4.74B
| $2.04M | ﹤0.01% |
822,417
+125,894
| +18% | +$351K |
|
1338
Tyler Technologies
TYL
$13.7B
| $2.04M | ﹤0.01% |
+4,055
| New | +$1.87M |
|
1339
HEICO Corp
HEI
$50.8B
| $2.04M | ﹤0.01% |
+9,108
| New | +$1.92M |
|
1340
Incyte
INCY
$26B
| $2.03M | ﹤0.01% |
33,542
-258,159
| -89% | -$14.6M |
|
1341
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.69B
| $2.03M | ﹤0.01% |
20,100
-8,500
| -30% | -$888K |
|
|
CNTA
1342
DELISTED
Centessa Pharmaceuticals
CNTA
| $2.03M | ﹤0.01% |
224,948
-6,617
| -3% | -$62.8K |
|
1343
Piper Sandler
PIPR
$5.24B
| $2.01M | ﹤0.01% |
34,936
-31,468
| -47% | -$1.61M |
|
1344
Lexicon Pharmaceuticals
LXRX
$1.04B
| $2M | ﹤0.01% |
1,190,448
+691,276
| +138% | +$1.24M |
|
|
WKME
1345
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $2M | ﹤0.01% |
143,153
-25,213
| -15% | -$247K |
|
1346
CACI
CACI
$11.3B
| $2M | ﹤0.01% |
+4,643
| New | +$1.9M |
|
|
MAQCW
1347
CALL
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
| $1.99M | ﹤0.01% |
180,000
| – | – |
|
1348
El Pollo Loco
LOCO
$497M
| $1.99M | ﹤0.01% |
175,670
+139,375
| +384% | +$1.39M |
|
1349
Cardinal Health
CAH
$54.5B
| $1.98M | ﹤0.01% |
+20,131
| New | +$2.05M |
|
1350
Fluence Energy
FLNC
$1.68B
| $1.98M | ﹤0.01% |
114,100
+78,344
| +219% | +$1.5M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.